As in other years, the meeting agenda will be build combining EBF contributions, invited experts or via submissions sent to us as part of the call for speakers. You can find the call for abstract here.
Themes for the 14th Open Symposium
Our agenda is very ambitious and sets the stage for the new era. You can submit an abstract for podium presentations/workshop with focus on below categories (including suggested sub-themes):
NCEs (chromatography focus): focus on scientific and regulatory challenges and best state of the art practices for
metabolite quantification
non-liquid matrix analysis
new tools surrounding Chromatography: Blue Sky – new technologies at our doorstep
NBE (LBA/CBA based): focus on scientific and regulatory challenges and best state of the art practices for
critical reagents,
immunocapture-LC/MS (hybrid) assays
PK interpretation of NBEs (total/Free..)
Bio-metabolism of Biotherapeutics
C> and new modalities: are we ready to support the next generation Pharma R&D challenges?
Immunogenicity: focus on what’s new/different and making sense for biologics, C>, new modalities and peptides
Biomarker Science:includes a spotlight on non-liquid matrices analysis for Biomarkers
Biosimilars:scientific and regulatory challenges for the BioA community
Regulations: risk based approach, GCP, data integrity, post Covid-19 inspection readiness (remote inspections), ICH M10 and new emerging guidelines as required
The Future of Bioanalysis: focus on the role of BioA
in speeding up drug development (process, tools, Risk based Approach),